OXURION Trademark

Trademark Overview


On Tuesday, December 18, 2018, a trademark application was filed for OXURION with the United States Patent and Trademark Office. The USPTO has given the OXURION trademark a serial number of 79253776. The federal status of this trademark filing is REGISTERED as of Tuesday, December 10, 2019. This trademark is owned by Oxurion. The OXURION trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Biopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, chemicals preparations and biological materials, all the foregoing being in the form of spatially defined arrays and solutions and reagents for medical laboratory use in diagnosing, monitoring, and predicting diseases and for measuring and predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; pharmaceutical substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical preparations and substances for the treatment or prevention of diabetes; medicines for treating or preventing diabetes; ophthalmic medicines and surgical fluids, ophthalmic pharmaceutical preparations; pharmaceutical eye drops

Medical services; veterinary services; consultancy services, namely, consultancy in the medical, veterinary and pharmaceutical treatment of patients in the fields of ophthalmology, diabetes and cardiovascular diseases; medical services, namely, cardiac and vascular therapeutic, prognostic and diagnostic testing services

Scientific and technological services, namely research and design relating thereto in the field of ophthalmology, in the field of diabetes and in the field of treatment of cardiovascular disease, cardiac disease and vascular disease; industrial analysis of the pharmaceutical preparations of others used for the treatment of ophthalmologic diseases, diabetes and cardiovascular diseases for quality control purposes; research services in the field of ophthalmology, diabetes and cardiovascular diseases; pharmaceutical and biopharmaceutical research and development; biopharmaceutical product evaluation; research in the field of treatment of cardiovascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals
oxurion

General Information


Serial Number79253776
Word MarkOXURION
Filing DateTuesday, December 18, 2018
Status700 - REGISTERED
Status DateTuesday, December 10, 2019
Registration Number5929399
Registration DateTuesday, December 10, 2019
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 24, 2019

Trademark Statements


Description of MarkThe mark consists of the wording "OXURION" in stylized text, where the letters "O" and "URION" are in blue and the "X" is in a larger, slanted font in green.
Goods and ServicesBiopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, chemicals preparations and biological materials, all the foregoing being in the form of spatially defined arrays and solutions and reagents for medical laboratory use in diagnosing, monitoring, and predicting diseases and for measuring and predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; pharmaceutical substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical preparations and substances for the treatment or prevention of diabetes; medicines for treating or preventing diabetes; ophthalmic medicines and surgical fluids, ophthalmic pharmaceutical preparations; pharmaceutical eye drops
Indication of Colors claimedThe color(s) blue and green is/are claimed as a feature of the mark.
Goods and ServicesMedical services; veterinary services; consultancy services, namely, consultancy in the medical, veterinary and pharmaceutical treatment of patients in the fields of ophthalmology, diabetes and cardiovascular diseases; medical services, namely, cardiac and vascular therapeutic, prognostic and diagnostic testing services
Goods and ServicesScientific and technological services, namely research and design relating thereto in the field of ophthalmology, in the field of diabetes and in the field of treatment of cardiovascular disease, cardiac disease and vascular disease; industrial analysis of the pharmaceutical preparations of others used for the treatment of ophthalmologic diseases, diabetes and cardiovascular diseases for quality control purposes; research services in the field of ophthalmology, diabetes and cardiovascular diseases; pharmaceutical and biopharmaceutical research and development; biopharmaceutical product evaluation; research in the field of treatment of cardiovascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 12, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 12, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 12, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOxurion
Party Type30 - Original Registrant
Legal Entity Type32 - NOT AVAILABLE
AddressBE

Party NameOxurion
Party Type20 - Owner at Publication
Legal Entity Type32 - NOT AVAILABLE
AddressBE

Party NameOxurion
Party Type10 - Original Applicant
Legal Entity Type32 - NOT AVAILABLE
AddressBE

Trademark Events


Event DateEvent Description
Thursday, March 7, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, March 12, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 13, 2019ASSIGNED TO EXAMINER
Saturday, March 16, 2019APPLICATION FILING RECEIPT MAILED
Monday, March 18, 2019NON-FINAL ACTION WRITTEN
Tuesday, March 19, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 27, 2019REFUSAL PROCESSED BY MPU
Thursday, March 28, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 12, 2019REFUSAL PROCESSED BY IB
Monday, July 22, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 22, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 22, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 22, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 23, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 16, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, August 16, 2019EXAMINERS AMENDMENT E-MAILED
Friday, August 16, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 16, 2019EXAMINER'S AMENDMENT ENTERED
Friday, August 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 18, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, September 24, 2019PUBLISHED FOR OPPOSITION
Tuesday, September 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, October 5, 2019NOTIFICATION PROCESSED BY IB
Tuesday, December 10, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, March 10, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, March 23, 2020FINAL DISPOSITION PROCESSED
Monday, March 23, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 10, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, December 10, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED